AFRM vs BOLT · P/E 590, rev $3.22B vs rev $7.7M
Affirm Holdings Inc (AFRM) versus Bolt Biotherapeutics (BOLT) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. BOLT currently screens at market cap $11.3M.
Not investment advice. Open the AFRM and BOLT stock pages for the full models.
Not investment advice.